Managing Risk of Your Global Single Use Supply Chain
With the rapid growth of single-use systems (SUS) for drug production, especially by drug manufacturers with multiple locations across the globe, there are many risks associated with underestimating the regulatory compliance, manufacturing and quality requirements of these systems. For example, using SUS introduces new logistics challenges that, if not properly understood and planned for, can leave biopharma manufacturers vulnerable to supply chain complexities.
To minimize these risks, biopharma manufacturers can benefit by adopting a global single-use supply chain strategy early in the drug development life cycle and carefully evaluating their chosen single-use equipment and materials suppliers. When reviewing a prospective supplier, there are two primary considerations for biopharma manufacturers to keep in mind: the regulatory and quality compliance and the supply chain operational excellence of the supplier.
Director – New Product Introduction, Single-use
Tim has more than 20 years of experience as an engineer and in business development with PAW BioScience Products, VWR and Biopure Corporation where he has designed single-use products, components and systems for the global drug and vaccine manufacturing industry.
From the small-scale bench to full commercial manufacturing, we enable our customers to reach the market with new treatments for patients, faster and safer. Learn more about our offering for biopharmaceutical manufacturing.